DMP: Dimethyl Pimelimidate Dinydrochloride

SECTION 2: Hazards identification

(29 CFR 1910.1200) Emergency overview Physical state Solid, [Powder.] Color + White.

Signal word

» WARNING!

Hazard statements

» CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION.

Precautionary statements

— : Avoid breathing dust, Use only with adequate ventilation, Avoid contact with eyes, skin and clothing. Keep container tightly closed, Wash thoroughly after handling, OSHAIHCS status + This material is considered hazardous by the

Potential Acute Health Effects

Inhalation Irritating to respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure, Ingestion + No known significant effects or critical hazards. Skin ‘Irritating to skin. Eyes ‘Irritating to eyes.

Potential chronic health

effects + Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. 12/17/2010. 18 Life Science Resesrct PO Bax 117 Rocklord. IL (8151 988-0747 wew.thermo.com Pierce Biotechnology Inc. 5747 N. hleridan Road 61105 (815) 968-7316 Fax DMP. Dimethyl Pimelimidate Dihydrochloride Carcinogenicity + No known significant effects or critical hazards, Mutagenicity + No known significant effects or critical hazards,

Teratogenic Effects

+ No known significant effects or critical hazards, Developmental effects + No known significant effects or critical hazards, Fertility effects + No known significant effects or critical hazards, Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin + Adverse symptoms may include the following: imitation redness Eyes : Adverse symptoms may include the following: pain or irritation walering redness Medical conditions : None known. aggravated by over- exposure See toxicological information (Section 11}